JP2008539182A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008539182A5 JP2008539182A5 JP2008508138A JP2008508138A JP2008539182A5 JP 2008539182 A5 JP2008539182 A5 JP 2008539182A5 JP 2008508138 A JP2008508138 A JP 2008508138A JP 2008508138 A JP2008508138 A JP 2008508138A JP 2008539182 A5 JP2008539182 A5 JP 2008539182A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- protein
- immunogenic fragment
- vaccine according
- excluded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960005486 vaccine Drugs 0.000 claims 43
- 239000012634 fragment Substances 0.000 claims 21
- 230000002163 immunogen Effects 0.000 claims 20
- 108090000623 proteins and genes Proteins 0.000 claims 20
- 102000004169 proteins and genes Human genes 0.000 claims 20
- 239000002671 adjuvant Substances 0.000 claims 7
- 208000015181 infectious disease Diseases 0.000 claims 6
- 231100000590 oncogenic Toxicity 0.000 claims 6
- 230000002246 oncogenic effect Effects 0.000 claims 6
- 241000341655 Human papillomavirus type 16 Species 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 230000002265 prevention Effects 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 101100209954 Human papillomavirus type 16 L1 gene Proteins 0.000 claims 3
- 101000641175 Human papillomavirus type 18 Major capsid protein L1 Proteins 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 230000005856 abnormality Effects 0.000 claims 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical group [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical group [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 2
- 230000002380 cytological effect Effects 0.000 claims 2
- 101150061050 CIN1 gene Proteins 0.000 claims 1
- 101150070189 CIN3 gene Proteins 0.000 claims 1
- 208000037581 Persistent Infection Diseases 0.000 claims 1
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 101150005988 cin2 gene Proteins 0.000 claims 1
- 230000003902 lesion Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000007764 o/w emulsion Substances 0.000 claims 1
- 229960002566 papillomavirus vaccine Drugs 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/114,301 US20050287161A1 (en) | 2002-12-20 | 2005-04-26 | Vaccine |
| PCT/EP2005/006461 WO2005123125A1 (en) | 2004-06-16 | 2005-06-14 | Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52 |
| US11/367,601 US7858098B2 (en) | 2002-12-20 | 2005-12-16 | Vaccine |
| PCT/EP2006/003809 WO2006114273A2 (en) | 2005-04-26 | 2006-04-24 | Vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008539182A JP2008539182A (ja) | 2008-11-13 |
| JP2008539182A5 true JP2008539182A5 (enExample) | 2009-04-23 |
Family
ID=37199195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008508138A Pending JP2008539182A (ja) | 2005-04-26 | 2006-04-24 | ワクチン |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1879614A2 (enExample) |
| JP (1) | JP2008539182A (enExample) |
| KR (1) | KR20080005583A (enExample) |
| AR (1) | AR053715A1 (enExample) |
| AU (1) | AU2006239471A1 (enExample) |
| CA (1) | CA2606206A1 (enExample) |
| EA (1) | EA013325B1 (enExample) |
| MX (1) | MX2007013475A (enExample) |
| NO (1) | NO20075185L (enExample) |
| SG (1) | SG159529A1 (enExample) |
| UY (1) | UY29499A1 (enExample) |
| WO (1) | WO2006114273A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009348078B2 (en) * | 2009-06-19 | 2013-03-14 | Eyegene Inc. | Vaccine for cervical cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
| US6908613B2 (en) * | 2000-06-21 | 2005-06-21 | Medimmune, Inc. | Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| GB0206360D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
| JP5475939B2 (ja) * | 2002-12-20 | 2014-04-16 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | Ｈｐｖ−１６およびｈｐｖ−１８ｌ１ｖｌｐワクチン |
| JP2008502633A (ja) * | 2004-06-16 | 2008-01-31 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | Ｈｐｖ１６およびｈｐｖ１８ならびにｈｐｖ３１、４５または５２から選ばれる少なくとも１つの別のｈｐｖ型に対するワクチン |
-
2006
- 2006-04-24 SG SG201000826-6A patent/SG159529A1/en unknown
- 2006-04-24 AU AU2006239471A patent/AU2006239471A1/en not_active Abandoned
- 2006-04-24 MX MX2007013475A patent/MX2007013475A/es unknown
- 2006-04-24 EP EP06753410A patent/EP1879614A2/en not_active Ceased
- 2006-04-24 EA EA200702077A patent/EA013325B1/ru unknown
- 2006-04-24 JP JP2008508138A patent/JP2008539182A/ja active Pending
- 2006-04-24 KR KR1020077027492A patent/KR20080005583A/ko not_active Ceased
- 2006-04-24 AR ARP060101618A patent/AR053715A1/es not_active Application Discontinuation
- 2006-04-24 CA CA002606206A patent/CA2606206A1/en not_active Abandoned
- 2006-04-24 WO PCT/EP2006/003809 patent/WO2006114273A2/en not_active Ceased
- 2006-04-26 UY UY29499A patent/UY29499A1/es not_active Application Discontinuation
-
2007
- 2007-10-11 NO NO20075185A patent/NO20075185L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1410805B1 (en) | Vaccine against HPV | |
| Lowy et al. | Prophylactic human papillomavirus vaccines | |
| Gambhira et al. | Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2 | |
| JP2006512413A5 (enExample) | ||
| US9149503B2 (en) | Papillomavirus-like particles (VLP) as broad spectrum human papillomavirus (HPV) vaccines | |
| CA2543928A1 (en) | Optimized expression of hpv 58 l1 in yeast | |
| CA2539168A1 (en) | Optimized expression of hpv 45 l1 in yeast | |
| CA2510457A1 (en) | Hpv-16 and -18 l1 vlp vaccine | |
| CA2519112A1 (en) | Optimized expression of hpv 31 l1 in yeast | |
| Huber et al. | A chimeric 18L1-45RG1 virus-like particle vaccine cross-protects against oncogenic alpha-7 human papillomavirus types | |
| Roden et al. | The impact of preventive HPV vaccination | |
| JP2008539184A5 (enExample) | ||
| JP2008539182A5 (enExample) | ||
| Webb et al. | Cervical cancer-causing human papillomaviruses have an alternative initiation site for the L1 protein | |
| JP2013540421A5 (enExample) | ||
| Mandic | Primary prevention of cervical cancer: prophylactic human papillomavirus vaccines | |
| CA2566620C (en) | Vaccine against hpv16 and hpv18 and at least another hpv type slected from hpv 31, 45 or 52 | |
| Hariharan et al. | Genotypes of the human papillomavirus: Relevance to Indian field trials of the vaccine | |
| CN101116745B (zh) | 人乳头瘤病毒的病毒样颗粒疫苗 | |
| US7858098B2 (en) | Vaccine | |
| CN100418577C (zh) | Hpv-16和hpv-18l1vlp疫苗 | |
| CN101217976A (zh) | 疫苗 | |
| 張士泰 | The prevalence of VAIN, CIN, and related HPV genotypes in Japanese women with abnormal cytology | |
| ZHENG et al. | Correlation Between Cervical Cancer HPV Infection and Cervical Intraepithelial | |
| Yin | Development of vaccine against human papillomavirus types 3, 10 and 77 |